354 related articles for article (PubMed ID: 23487391)
1. Decreasing incidence of herpes zoster in the highly active antiretroviral therapy era.
Moanna A; Rimland D
Clin Infect Dis; 2013 Jul; 57(1):122-5. PubMed ID: 23487391
[TBL] [Abstract][Full Text] [Related]
2. Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
Grabar S; Tattevin P; Selinger-Leneman H; de La Blanchardiere A; de Truchis P; Rabaud C; Rey D; Daneluzzi V; Ferret S; Lascaux AS; Hanslik T; Costagliola D; Launay O;
Clin Infect Dis; 2015 Apr; 60(8):1269-77. PubMed ID: 25601456
[TBL] [Abstract][Full Text] [Related]
3. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
[TBL] [Abstract][Full Text] [Related]
5. Varicella zoster as a manifestation of immune restoration disease in HIV-infected children.
Tangsinmankong N; Kamchaisatian W; Lujan-Zilbermann J; Brown CL; Sleasman JW; Emmanuel PJ
J Allergy Clin Immunol; 2004 Apr; 113(4):742-6. PubMed ID: 15100682
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study.
Hung CC; Hsiao CF; Wang JL; Chen MY; Hsieh SM; Sheng WH; Chang SC
Int J STD AIDS; 2005 Oct; 16(10):673-6. PubMed ID: 16212714
[TBL] [Abstract][Full Text] [Related]
7. Varicella-Zoster virus-specific cell-mediated immunity in HIV-infected children receiving highly active antiretroviral therapy.
Weinberg A; Wiznia AA; LaFleur BJ; Shah S; Levin MJ
J Infect Dis; 2004 Jul; 190(2):267-70. PubMed ID: 15216460
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan.
Lee YC; Hung CC; Tsai MS; Zhang JY; Wu PY; Yang SP; Luo YZ; Chang HY; Liu WC; Sun HY; Chang SC
J Microbiol Immunol Infect; 2018 Feb; 51(1):38-44. PubMed ID: 27329131
[TBL] [Abstract][Full Text] [Related]
9. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.
Gebo KA; Kalyani R; Moore RD; Polydefkis MJ
J Acquir Immune Defic Syndr; 2005 Oct; 40(2):169-74. PubMed ID: 16186734
[TBL] [Abstract][Full Text] [Related]
10. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
[TBL] [Abstract][Full Text] [Related]
11. Providers' lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination.
Aziz M; Kessler H; Huhn G
Int J STD AIDS; 2013 Jun; 24(6):433-9. PubMed ID: 23970744
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster among HIV-infected patients in the highly active antiretroviral therapy era: Korean HIV cohort study.
Song JY; Lee JS; Jung HW; Choi HJ; Lee JS; Eom JS; Cheong HJ; Jung MH; Kim WJ
J Acquir Immune Defic Syndr; 2010 Mar; 53(3):417-8. PubMed ID: 20190589
[No Abstract] [Full Text] [Related]
14. Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.
Levin MJ; Anderson JP; Seage GR; Williams PL;
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):182-91. PubMed ID: 19131890
[TBL] [Abstract][Full Text] [Related]
15. Highly active antiretroviral therapy-induced immune recovery in an HIV-positive patient with a history of herpes zoster ophthalmicus.
Pagani JM; Duan JQ
Optometry; 2011 Feb; 82(2):77-82. PubMed ID: 21147041
[TBL] [Abstract][Full Text] [Related]
16. Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy.
Posavad CM; Wald A; Kuntz S; Huang ML; Selke S; Krantz E; Corey L
J Infect Dis; 2004 Aug; 190(4):693-6. PubMed ID: 15272395
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
18. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
Kwara A; Flanigan TP; Carter EJ
Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
[TBL] [Abstract][Full Text] [Related]
19. Herpes zoster as an immune restoration disease in AIDS patients during therapy including protease inhibitors.
Dunić I; Djurković-Djaković O; Vesić S; Zerjav S; Jevtović D
Int J STD AIDS; 2005 Jul; 16(7):475-8. PubMed ID: 16004625
[TBL] [Abstract][Full Text] [Related]
20. Impact of Antiretroviral Therapy on the Risk of Herpes Zoster among Human Immunodeficiency Virus-Infected Individuals in Tanzania.
Kawai K; Hawkins CA; Hertzmark E; Francis JM; Sando D; Muya AN; Ulenga N; Fawzi WW
Am J Trop Med Hyg; 2018 Feb; 98(2):396-401. PubMed ID: 29313475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
